Progress in drug development against HIV

According to there are more than 7 000 clinical trials that investigate various aspects of HIV infected patients including investigational research of new medicines against HIV, AIDS and AIDS-related conditions. In terms of drug development, there are four major areas that are still subject to intensive research driven by significant medical needs. These areas are; (i) Clinical challenges in ART-resistant HIV patients; (ii) Clinical challenges in ART-intolerant HIV patients; (iii) Compliance issues due to requirement of three to four daily doses of ART-medicines; (iv) Focused research to target mechanism of immune system regulation. In addition, there is a health economy dimension that drives development of new drugs namely the cost of ART treatment, which still is a problem in developing countries. More than fifty companies are today involved in HIV drug development, which includes development of vaccines, immune modulators and new and more effective ART drugs.


Company overview HIV progress – 1

Cure for HIV – 1

Recent Posts

Start typing and press Enter to search